A growing body of evidence supports a central role for proinflammatory cytokines, particularly tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6), in the development of NASH [26]. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.